百时美施贵宝(BMY)股吧_百时美施贵宝怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
192	0	百时美施贵宝(BMY.US)被质疑拖延抗癌药审批面临67亿美元诉讼	智通财经	11-15 03:45
2634	2	健讯Daily \| 第七届中国国际进口博览会开幕；《关于加强药品受托生产监督管理工作的公告（征求意见稿）》公开征求意见	百时美施贵宝资讯	11-06 09:10
207	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	11-06 09:51
203	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	11-06 09:51
206	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	11-06 09:51
206	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	11-06 09:51
201	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	11-06 09:51
344	0	欧狄沃联合含顺铂化疗获批尿路上皮癌一线治疗适应症	百时美施贵宝资讯	11-05 05:42
371	0	百时美施贵宝：欧狄沃联合含顺铂化疗获批尿路上皮癌一线治疗适应症	百时美施贵宝资讯	11-05 11:40
223	0	Report of proposed sale of securities	百时美施贵宝资讯	11-05 12:35
343	0	百时美施贵宝(BMY.US)潜在重磅疗法3期积极数据公布用于治疗精神分裂症	智通财经	11-03 07:39
251	0	Quarterly report [Sections 13 or 15(d)]	百时美施贵宝资讯	11-01 12:24
456	0	百时美施贵宝第三季度营收119亿美元	百时美施贵宝资讯	10-31 10:05
249	0	Current report, items 2.02, 7.01, and 9.01	百时美施贵宝资讯	10-31 07:59
1891	11	医保谈判第三日“开锣”，再鼎、迪哲、神威等企业进场	再鼎医药资讯	10-29 08:38
705	0	陈吉宁会见美国百时美施贵宝公司首席执行官博科思以创新举措支持生物医药产业发展	百时美施贵宝资讯	10-25 06:13
469	0	陈吉宁会见美国百时美施贵宝公司首席执行官博科思	百时美施贵宝资讯	10-24 11:41
465	0	陈吉宁会见美国百时美施贵宝公司首席执行官博科思	百时美施贵宝资讯	10-24 11:27
3813	4	健讯Daily｜多家上市公司旗下药房涉大额骗保案；优赫得在华获批，成为首个且唯一靶向HER2突变晚期非小细胞肺癌ADC药物	百时美施贵宝资讯	10-15 08:41
481	0	欧狄沃联合逸沃获批一线治疗结直肠癌	百时美施贵宝资讯	10-14 05:24
468	0	百时美施贵宝(BMY.US)纳武利尤单抗联合伊匹木单抗疗法在华获批	智通财经	10-14 01:58
660	0	百时美施贵宝：欧狄沃与逸沃双免疫联合疗法新适应症在华获批	百时美施贵宝资讯	10-14 10:36
281	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-04 06:42
284	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:08
286	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:07
284	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:07
284	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:07
278	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:07
285	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	10-03 06:05
1342	0	百利天恒BL-B01D1获临床研究新进展合作方百时美施贵宝积极推进产品全球临床开发	百利天恒-U资讯	09-29 11:49
1149	0	百利天恒：BL-B01D1联合用药临床研究获FDA许可	百利天恒-U资讯	09-29 10:01
489	0	百亿级宝剑出鞘？百时美施贵宝不藏了	药械Talks	09-28 03:41
527	0	百时美施贵宝美股盘前涨逾5%	百时美施贵宝资讯	09-27 04:15
695	0	百时美施贵宝COBENFY在美国获批用于口服治疗成人精神分裂症	百时美施贵宝资讯	09-27 10:57
640	0	又一款创新药遭百时美施贵宝退货，连续退货或与战略调整有关	百时美施贵宝资讯	09-24 11:16
321	0	BMS再次退货：Immatics的MAGEA4/8 TCR双抗被退	药研网	09-20 02:10
1258	1	百时美施贵宝原研肿瘤治疗药物Abraxane在中国正式上市	百时美施贵宝资讯	09-02 02:59
881	0	首款国产KRAS抑制剂氟泽雷塞获批上市，信达生物引领抗癌新篇章	摩熵医药	08-23 03:08
1279	1	21健讯Daily \| 科伦博泰双抗ADC授权给默沙东；同源康医药在港挂牌上市	默沙东资讯	08-21 11:57
556	0	人民会客厅·外企谈信心百时美施贵宝朱正缨：加速创新研发满足更多中国患者治疗需求	百时美施贵宝资讯	08-16 02:22
355	1	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	08-06 06:18
345	1	[Amend] Initial statement of beneficial ownership of securities	百时美施贵宝资讯	08-01 08:31
446	0	传奇生物想超越你	飞龙在天9999999	08-07 10:45
318	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	08-01 08:26
132367	177	全球市场：美股三大指数均涨逾1% 道指周线四连涨	Meta Platforms I资讯	07-27 05:32
368	0	Quarterly report [Sections 13 or 15(d)]	百时美施贵宝资讯	07-27 12:27
333	0	Current report, items 2.02, 7.01, and 9.01	百时美施贵宝资讯	07-26 08:46
436	0	0726 提醒：日内请重点关注（以下均为北京时间）	东吴期货官方	07-26 09:03
392	0	【速递】FR ADC遭受退货，BMS/卫材超30亿美元战略合作终止	动态宝	07-19 03:45
326	0	Initial statement of beneficial ownership of securities	百时美施贵宝资讯	07-03 09:29
315	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 07:26
315	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 06:26
316	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 06:26
313	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 05:51
320	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 05:51
307	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	07-03 05:49
326	0	Annual report of employee stock purchase, savings and similar plans	百时美施贵宝资讯	06-26 04:41
330	0	Annual report of employee stock purchase, savings and similar plans	百时美施贵宝资讯	06-26 04:41
321	0	Annual report of employee stock purchase, savings and similar plans	百时美施贵宝资讯	06-26 04:38
372	0	Current report, items 5.02 and 9.01	百时美施贵宝资讯	06-18 12:00
632	0	百时美施贵宝CAR-T疗法获美国FDA批准	百时美施贵宝资讯	05-31 09:18
370	0	瑞普替尼胶囊获批上市用于治疗ROS1阳性非小细胞肺癌	经济观察报	05-12 02:13
318	0	Current report, items 5.03, 5.07, and 9.01	百时美施贵宝资讯	05-10 04:59
383	0	百时美施贵宝皮下注射版PD-1申报上市；先为达GLP-1授权海外药企	氨基观察	05-08 11:09
325	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	05-04 07:00
451	0	全球首创心肌肌球蛋白抑制剂迈凡妥在中国获批	百时美施贵宝资讯	04-30 01:01
470	0	百时美施贵宝：心肌肌球蛋白抑制剂迈凡妥在中国获批用于治疗梗阻性肥厚型心肌病成人患者	百时美施贵宝资讯	04-30 11:34
274	0	Quarterly report [Sections 13 or 15(d)]	百时美施贵宝资讯	04-26 01:14
464	0	百时美施贵宝Q1由盈转亏大幅下调今年盈利预期	格隆汇	04-26 12:31
300	0	Current report, items 2.02, 7.01, and 9.01	百时美施贵宝资讯	04-25 07:57
271	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	百时美施贵宝资讯	04-22 08:33
328	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 09:24
326	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 09:19
332	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 09:15
327	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 08:16
331	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 08:15
330	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 08:12
330	0	Statement of changes in beneficial ownership of securities	百时美施贵宝资讯	04-03 08:12
299	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	百时美施贵宝资讯	03-29 06:11
303	0	Other definitive proxy statements	百时美施贵宝资讯	03-29 06:08

emytylist